|
"su wei wen"的相關文件
顯示項目 11-34 / 34 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-05-21T11:40:40Z |
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan
|
Hsieh, Meng Hsuan; Bair, Ming Jong; Tsai, Pei Chien; Tseng, Kuo Chih; Lo, Ching Chu; Chen, Chi Yi; Kuo, Hsing Tao; Hung, Chao Hung; Lai, Hsueh Chou; Peng, Cheng Yuan; Wang, Jing Houng; Chen, Jyh Jou; Lee, Pei Lun; Chien, Rong Nan; Yang, Chi Chieh; Lo, Gin Ho; Kao, Jia-Horng; CHUN-JEN LIU; CHEN-HUA LIU; Yan, Sheng Lei; Lin, Chun Yen; Su, Wei Wen; Chu, Cheng Hsin; Chen, Chih Jen; Tung, Shui Yi; Tai, Chi Ming; Lin, Chih Wen; Cheng, Pin Nan; Chiu, Yen Cheng; CHIA-CHI WANG; Cheng, Jin Shiung; Tsai, Wei Lun; Lin, Han Chieh; Huang, Yi Hsiang; Yeh, Ming Lun; Huang, Chung Feng; Huang, Jee Fu; Dai, Chia Yen; Yu, Ming Lung; Chuang, Wan Long |
| 中山醫學大學 |
2021-05-14 |
Type 2 diabetes and the risk of colorectal polyps A retrospective nationwide population-based study
|
Hsu Po-Ke; Huang Jing-Yang; Su Wei-Wen; Wei James Cheng-Chung |
| 臺大學術典藏 |
2021-01-18T09:12:03Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
CHEN-HUA LIU; Chen, Chi Yi; Su, Wei Wen; Tseng, Kuo Chih; Lo, Ching Chu; CHUN-JEN LIU; Chen, Jyh Jou; Peng, Cheng Yuan; Shih, Yu Lueng; Yang, Sheng Shun; Huang, Chia Sheng; Huang, Ke Jhang; Chang, Chi Yang; Tsai, Ming Chang; Kao, Wei Yu; Fang, Yo Jen; Chen, Po Yueh; Su, Pei Yuan; Tseng, Chih Wei; Huang, Jow Jyh; Lee, Pei Lun; Lai, Hsueh Chou; Hsieh, Tsai Yuan; Chang, Chung Hsin; Huang, Yi Jie; Lee, Fu Jen; Chang, Chun Chao; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:39:55Z |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
|
Yu, Ming-Lung; HUNG-CHIH YANG; CHUN-JEN LIU; Lee, Chuan-Mo; Lee, Chuan-Mo; PEI-JER CHEN; Chen, Chi-Ling; Chen, Chi-Ling; CHEN-HUA LIU; Chuang, Wan-Long; Lu, Sheng-Nan; Lu, Sheng-Nan; DING-SHINN CHEN; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Wu, Shun-Sheng; Wu, Shun-Sheng; Liao, Li-Ying; Kuo, Hsing-Tao; Kuo, Hsing-Tao; Chao, You-Chen; Tung, Shui-Yi; Tung, Shui-Yi; Yang, Sien-Sing; Kao, Jia-Horng; Kao, Jia-Horng; Su, Wei-Wen; Su, Wei-Wen; Lin, Chih-Lin; Lin, Chih-Lin; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Liu, Chun-Jen; Liu, Chun-Jen; Yu, Ming-Lung;Lee, Chuan-Mo;Chen, Chi-Ling;Chuang, Wan-Long;Lu, Sheng-Nan;Liu, Chen-Hua;Wu, Shun-Sheng;Liao, Li-Ying;Kuo, Hsing-Tao;Chao, You-Chen;Tung, Shui-Yi;Yang, Sien-Sing;Kao, Jia-Horng;Su, Wei-Wen;Lin, Chih-Lin;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T07:37:25Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu, Chun-Jen;Chuang, Wan-Long;Lee, Chuan-Mo;Yu, Ming-Lung;Lu, Sheng-Nan;Wu, Shun-Sheng;Chen, Chi-Ling;Yang, Sien-Sing;Kao, Jia-Horng;Liu, Chen-Hua;Su, Wei-Wen;Jeng, Yung-Ming;Chen, Pei-Jer;Chen, Ding-Shinn; CHUN-JEN LIU; YUNG-MING JENG; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN; WU, SHUN-SHENG; CHEN, CHI-LING; YANG, SIEN-SING; KAO, JIA-HORNG; LIU, CHEN-HUA; SU, WEI-WEN; JENG, YUNG-MING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 國立臺灣大學 |
2016 |
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Bair, Ming-Jong; Liang, Cheng-Chao; Lei, Yung-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立成功大學 |
2015-09-14 |
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
|
Yang, Chi-Chieh; Tsai, Wei-Lun; Su, Wei-Wen; Huang, Chung-Feng; Cheng, Pin-Nan; Lo, Ching-Chu; Tseng, Kuo-Chih; Mo, Lein-Ray; Wang, Chun-Hsiang; Hsu, Shih-Jer; Lai, Hsueh-Chou; Su, Chien-Wei; Liu, Chun-Jen; Peng, Cheng-Yuan; Yu, Ming-Lung |
| 國立臺灣大學 |
2015 |
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
|
Yang, Chi-Chieh; Tsai, Wei-Lun; Su, Wei-Wen; Huang, Chung-Feng; Cheng, Pin-Nan; Lo, Ching-Chu; Tseng, Kuo-Chih; Mo, Lein-Ray; Wang, Chun-Hsiang; Hsu, Shih-Jer; Lai, Hsueh-Chou; Su, Chien-Wei; Liu, Chun-Jen; Peng, Cheng-Yuan; Yu, Ming-Lung; 徐士哲; 劉俊人 |
| 國立臺灣大學 |
2015 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立成功大學 |
2014-11 |
Safety and rapid prediction of treatment futility of boceprevir with peginterferon-ribavirin for Asian treatment experienced HCV-1 patients
|
Yu, Ming Lung; Yang, Chi Chieh; Wei-Lun, Tsai; Su, Wei Wen; Cheng, Pin Nan; Lo, Ching Chu; Tseng, Kuo Chih; Mo, Lein Ray; Chun-Hsiang, Wang; Hsu, Shih Jer; Lai, Hsueh Chou; Su, Chien Wei; Liu, Chun Jen |
| 臺北醫學大學 |
2014 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study
|
Su, Tung-Hung;Hu, Tsung-Hui;Chen, Chi-Yi;Huang, Yi-Hsiang;Chuang, Wan-Long;Lin, Chun-Che;Wang, Chia-Chi;Su, Wei-Wen;Peng, Cheng-Yuan;Chien, Rong-Nan;Mo, Lein-Ray;Huang, Yi-Wen;Chen, Ming-Yao;Lin, Chih-Lin;Chen, Tsung-Ming;Wang, Horng-Yuan;Tseng, Kuo-Chih;Yang, Sheng-Shun;Hsu, Shih-Jer;Suk, Fat-Moon;Hu, Chi-Tan;Hsieh, Tsai-Yuan;Ming-jong, Bair;Liang, Cheng-Chao;Tseng, Tai-Chung;Chen, Chi-Ling;Kao, Jia-Horng |
| 國立臺灣大學 |
2014 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Peng, Cheng-Yuan; Chien, Rong-Nan; Mo, Lein-Ray; Huang, Yi-Wen; Chen, Ming-Yao; Lin, Chih-Lin; Chen, Tsung-Ming; Wang, Horng-Yuan; Tseng, Kuo-Chih; Yang, Sheng-Shun; Hsu, Shih-Jer; Suk, Fat-Moon; Hu, Chi-Tan; Hsieh, Tsai-Yuan; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up
|
Yu, Ming-Lung; Lee, Chuan-Mo; Chen, Chi-Ling; Chuang, Wan-Long; Lu, Sheng-Nan; Liu, Chen-Hua; Wu, Shun-Sheng; Liao, Li-Ying; Kuo, Hsing-Tao; Chao, You-Chen; Tung, Shui-Yi; Yang, Sien-Sing; Kao, Jia-Horng; Su, Wei-Wen; Lin, Chih-Lin; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 |
| 亞洲大學 |
2010 |
Protein Kinase C Alpha Location and the Expression of Phospho-MEK and MDR1 in Hepatitis Virus-Related Hepatocellular Carcinoma Biopsies
|
;Lin, Chien-Chung;Hwang, Jin-Ming;Tsai, Min-Ting;Su, Wei-Wen;Chen, Li-Mien;Lai, Tung-Yuan;Hsu, Hsi-Hsien;Yen, Shiow-Kang;黃志揚;HUANG, CHIH-YANG;Liu, Jer-Yuh |
| 國立成功大學 |
2009-12 |
Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas
|
Su, Wei-Wen; Chen, Chien-Hung; Lin, Hans Hsienhong; Yang, Sheng-Shun; Chang, Ting-Tsung; Cheng, Ken-Sheng; Wu, Jaw-Ching; Wu, Shun-Sheng; Lee, Chuan-Mo; Changchien, Chi-Sin; Chen, Chien-Jen; Sheu, Jin-Chuan; Chen, Ding-Shinn; Lu, Sheng-Nan |
| 淡江大學 |
2009 |
吳晟作品中的鄉土
|
蘇惟文; Su, Wei-wen |
| 國立臺灣大學 |
2009 |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses
|
劉俊人; 莊萬龍; 李全謨; 余明隆; 盧勝男; 吳順生; 陳祈玲; 楊賢馨; 高嘉宏; 劉振驊; 蘇維文; 鄭永銘; 陳培哲; 陳定信; LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN; WU, SHUN-SHENG; CHEN, CHI-LING; YANG, SIEN-SING; KAO, JIA-HORNG; LIU, CHEN-HUA; SU, WEI-WEN; JENG, YUNG-MING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 國立臺灣大學 |
2009 |
GEOGRAPHIC VARIATIONS OF PREDOMINANTLY HEPATITIS C VIRUS ASSOCIATED MALE HEPATOCELLULAR CARCINOMA TOWNSHIPS IN TAIWAN: IDENTIFICATION OF POTENTIAL HIGH HCV ENDEMIC AREAS
|
蘇維文; 陳健弘; 楊勝舜; 張定宗; 鄭庚申; 吳肇卿; 吳順生; 李全謨; 張簡吉幸; 陳建仁; 許金川; 陳定信; 盧勝男; SU, WEI-WEN; CHEN, CHIEN-HUNG; LIN, HANS HSIEN-HONG; YANG, SHENG-SHUN; CHANG, TING-TSUNG; CHENG, KEN- SHENG; WU, JAW-CHING; WU, SHUN-SHENG; LEE, CHUAN- MO; CHANGCHIEN, CHI-SIN; CHEN, CHIEN-JEN; SHEU, JIN-CHUAN; CHEN, DING-SHINN; LU, SHENG-NAN |
| 國立成功大學 |
2006-10-15 |
Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan
|
Lu, Sheng-Nan; Su, Wei-Wen; Yang, Sheng-Shun; Chang, Ting-Tsung; Cheng, Ken-Sheng; Wu, Jaw-Ching; Lin, Hans Hsienhong; Wu, Shun-Sheng; Lee, Chuan-Mo; Changehien, Chi-Sin; Chen, Chien-Jen; Sheu, Jin-Chuan; Chen, Ding-Shinn; Chen, Chien-Hung |
| 國立成功大學 |
2006-10 |
Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: Analysis of 11 312 patients in Taiwan
|
Chen, Chien-Hung; Su, Wei-Wen; Yang, Sheng-Shun; Chang, Ting-Tsung; Cheng, Ken-Sheng; Lin, Hans Hsienhong; Wu, Shun-Sheng; Lee, Chuan-Mo; Changchien, Chi-Sin; Chen, Chien-Jen; Sheu, Jin-Chuan; Chen, Ding-Shinn; Lu, Sheng-Nan |
| 國立成功大學 |
2006-09 |
Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients
|
Chen, Chien-Hung; Chang, Ting-Tsung; Cheng, Ken-Sheng; Su, Wei-Wen; Yang, Sheng-Shun; Lin, Hans Hsienhong; Wu, Shun-Sheng; Lee, Chuan-Mo; Changchien, Chi-Sin; Chen, Chien-Jen; Sheu, Jin-Chuan; Chen, Ding-Shinn; Lu, Sheng-Nan |
| 國立臺灣大學 |
2006 |
SECULAR TRENDS AND GEOGRAPHIC VARIATIONS OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA IN TAIWAN
|
LU, SHENG-NAN; SU, WEI-WEN; YANG, SHENG-SHUN; CHANG, TING-TSUNG; CHENG, KEN-SHENG; WU, JAW-CHING; LIN, HANS, HSIEN-HONG; WU, SHUN-SHENG; LEE, CHUAN-MO; CHANGCHIEN, CHI-SIN; CHEN, CHIEN-JEN; SHEU, JIN-CHUAN; CHEN, DING-SHINN; CHEN, CHIEN-HUNG; 盧勝男; 蘇維文; 楊勝舜; 張定宗; 鄭庚申; 吳肇卿; 林憲宏; 吳順生; 李全謨; 張簡吉幸; 陳建仁; 許金川; 陳定信; 陳健弘 |
| 國立臺灣大學 |
2006 |
Do Young Hepatocellular Carcinoma Patients Have Worse Prognosis? The Paradox of Age as a Prognostic Factor in the Survival of Hepatocellular Carcinoma Patients
|
陳健弘; 張定宗; 鄭庚申; 蘇維文; 楊勝舜; 林憲宏; 吳順生; 李全謨; 張簡吉幸; 陳建仁; 許金川; 陳定信; 盧勝男; CHEN, CHIEN-HUNG; CHANG, TING-TSUNG; CHENG, KEN-SHENG; SU, WEI-WEN; YANG, SHENG-SHUN; LIN, HANS HSIEN-HONG; WU, SHUN-SHENG; LEE, CHUAN-MO; CHANGCHIEN, CHI-SIN; CHEN, CHIEN-JEN; SHEU, JIN-CHUAN; CHEN, DING-SHINN; LU, SHENG-NAN |
| 國立臺灣大學 |
2006 |
Long-Term Trends and Geographic Variations in the Survival of Patients with Hepatocellular Carcinoma: Analysis of 11 312 Patients in Taiwan
|
陳健弘; 蘇維文; 楊勝舜; 張定宗; 鄭庚申; 林憲宏; 吳順生; 李全謨; 張簡吉幸; 陳建仁; 許金川; 陳定信; 盧勝男; CHEN, CHIEN-HUNG; SU, WEI-WEN; YANG, SHENG-SHUN; CHANG, TING-TSUNG; CHENG, KEN-SHENG; LIN, HANS HSIEN-HONG; WU, SHUN-SHENG; LEE, CHUAN-MO; CHANGCHIEN, CHI-SIN; CHEN, CHIEN-JEN; SHEU, JIN-CHUAN; CHEN, DING-SHINN; LU, SHENG-NAN |
顯示項目 11-34 / 34 (共1頁)
1
每頁顯示[10|25|50]項目
|
